4.6 Article

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis

Yanmei Dai et al.

Summary: The combination therapy of TACE and sorafenib significantly improves time to progression and progression-free survival, and reduces the risk of adverse reactions for unresectable HCC, especially when used before TACE. The meta-analysis showed slightly improved objective response rate and disease control rate in the TACE + sorafenib group, with higher incidence of adverse reactions compared to the TACE + placebo / alone group. Subgroup analysis indicated that the combination therapy before TACE was more effective in prolonging time to progression.

TRANSLATIONAL ONCOLOGY (2021)

Review Oncology

Transplant Oncology: An Evolving Field in Cancer Care

Maen Abdelrahim et al.

Summary: Transplant oncology is a promising concept that combines oncology, transplant medicine, and surgery to improve patient survival and quality of life, especially for hepatobiliary malignancies. Liver transplantation has shown significant improvement in treating hepatobiliary malignancies and CRC patients with liver metastases, but its indications only improve patient survival in the setting of limited systemic therapy options.

CANCERS (2021)

Review Gastroenterology & Hepatology

Role of locoregional therapies in the wake of systemic therapy

Daniel H. Palmer et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma Survival by Etiology: A SEER-Medicare Database Analysis

Gagandeep Brar et al.

HEPATOLOGY COMMUNICATIONS (2020)

Article Gastroenterology & Hepatology

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach et al.

HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

Review Medicine, General & Internal

Hepatocellular carcinoma

Alejandro Forner et al.

LANCET (2018)

Article Gastroenterology & Hepatology

Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials

Antonio Facciorusso et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)

Article Oncology

Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment

Masatoshi Kudo et al.

LIVER CANCER (2017)

Article Gastroenterology & Hepatology

Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata et al.

HEPATOLOGY INTERNATIONAL (2017)

Review Gastroenterology & Hepatology

The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial

Riccardo Lencioni et al.

JOURNAL OF HEPATOLOGY (2016)

Review Oncology

Hepatocellular carcinoma: From diagnosis to treatment

Miral Sadaria Grandhi et al.

SURGICAL ONCOLOGY-OXFORD (2016)

Article Gastroenterology & Hepatology

Hepatocellular carcinoma review: Current treatment, and evidence-based medicine

Ali Raza et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

The Global Epidemiology of Hepatocellular Carcinoma: Present and Future

Katherine A. McGlynn et al.

CLINICS IN LIVER DISEASE (2011)

Editorial Material Gastroenterology & Hepatology

Management of Hepatocellular Carcinoma: An Update

Jordi Bruix et al.

HEPATOLOGY (2011)

Review Multidisciplinary Sciences

Angiogenesis in cancer and other diseases

P Carmeliet et al.

NATURE (2000)